Inhibikase Therapeutics, Inc. Common Stock

$1.46

Change

+0.02(+1.04%)

Volume

8.407K($12.29K)

Market Capitalization

$108.79M

Inhibikase Therapeutics Price Charts

Inhibikase Therapeutics Price Chart7:10 PM4:30 AM5:50 AM7:10 AM8:30 AM9:50 AM11:10 AM1.501.491.481.481.471.461.45

Inhibikase Therapeutics Market Segments

Regular Trading Hours

+0.01(+0.69%)
Open$1.45
Close$1.46
Low$1.45
Low Change0.00 (0.00%)
High$1.47
High Change+0.02 (+1.38%)
Range$0.02
Volume7.189K
Dollar Volume$10.50K

Premarket

-0.03(-2.00%)
Open$1.50
Close$1.47
Low$1.47
Low Change-0.03 (-2.00%)
High$1.50
High Change+0.00 (+0.00%)
Range$0.03
Volume1.218K
Dollar Volume$1.79K

After Hours Yesterday

-0.04(-2.72%)
Open$1.47
Close$1.43
Low$1.43
Low Change-0.04 (-2.72%)
High$1.47
High Change+0.00 (+0.00%)
Range$0.04
Volume10.261K
Dollar Volume$14.67K

Regular Trading Hours Yesterday

-0.03(-1.70%)
Open$1.47
Close$1.45
Low$1.43
Low Change-0.04 (-2.72%)
High$1.52
High Change+0.05 (+3.40%)
Range$0.09
Volume81.736K
Dollar Volume$118.11K

Premarket Yesterday

*No Trades in Segment

Inhibikase Therapeutics Stock Splits

There has been 1 stock split for Inhibikase Therapeutics (IKT). The reverse stock split occured on June 30, 2023 and reduced the outstanding shares at a ratio of 6:1.

DateTypeRatio
June 30, 2023Reverse6:1